Eric Smart Named President and CEO of Coldstream Laboratories Inc.

Eric Smart Named President and CEO of Coldstream Laboratories Inc.

10/29/2012 11:05:51 AM

LEXINGTON, KY--(Marketwire - October 29, 2012) -

Coldstream Laboratories Inc.
Eric W. Smart has been named the new President and CEO of Coldstream Laboratories Inc., the largest sterile pharmaceutical manufacturing facility in Kentucky.

Smart brings to Coldstream over 20 years of leadership experience in the area of custom manufacturing and contract research services. Most recently, he served as Coldstream's Executive Vice President and led the Business Development, Marketing, and Project Management Teams.

Prior to Coldstream, Smart held senior leadership positions at AMRI and Organichem Corporation. Mr. Smart holds a Bachelor's degree in Chemistry from Vanderbilt University and earned his MBA at the University of Maryland. Prior to entering the pharmaceutical industry, Mr. Smart served eight years as an officer in the US Navy.

Smart will head a staff of 75 who provide a full range of services to support the development and cGMP manufacture of sterile injectable products for international biotech and pharmaceutical clients requiring small batch sizes to support clinical studies and commercial distribution.

"Mr. Smart is a results-focused leader who has been an integral part of Coldstream for the past five years," said John Fallone, Chairman of the Board for Coldstream Laboratories. "With Mr. Smart's proven track record and dedication to Coldstream's success, we are confident that he is the right person to lead Coldstream into its next phase of growth."

"Coldstream has evolved into a prominent small volume parenteral manufacturer during my tenure here," said Smart, who played a key role in transforming Organichem into a leading supplier of large-scale custom synthesis services to the global pharmaceutical industry. "I am excited to have this opportunity to continue that effort."

Smart replaces Larry Kranking, who retired after holding the position since 2010.

Coldstream Laboratories Inc. is a specialty manufacturer of sterile injectable drugs and operates a state-of-the-art parenteral manufacturing facility in Lexington, KY. For more information, visit or email

Suggested Articles

Myovant’s uterine fibroid drug reduced blood loss in nearly three-quarters of patients, trouncing placebo in the second of two phase 3 studies.

The cystic fibrosis biotech unveiled Belous’ appointment alongside news of the promotion of Geoff Gilmartin to the CMO position.

The series C round is the latest in a series of boosts for Frequency’s attempts to tackle hearing loss through the activation of progenitor cells.